| Reviewer | Employment | Research grant | Other research support | Speakers’ bureau/honoraria | Expert witness | Ownership interest | Consultant/advisory board | Other |
|---|---|---|---|---|---|---|---|---|
| Jordi Bañeras | Hospital Universitari Vall Hebron (Spain) | None | None | None | None | None | None | None |
| Shohreh F. Farzan | Keck School of Medicine of the University of Southern California | None | None | None | None | None | None | None |
| Jaymie Meliker | Stony Brook University | NIH† | None | None | None | None | None | None |
| Jonathan D. Newman | New York University Grossman School of Medicine | None | NIH (Have received salary support as co‐director of the Clinical Coordiating Center and co‐site PI for the TACT2 trial)* | None | None | None | None | None |
| Sung Kyun Park | University of Michigan School of Public Health | None | None | None | None | None | None | None |
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12‐month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*Modest.
†Significant.